SEC Form 4 · accession 0001520138-18-000297
GREY CLOAK TECH INC. · GRCK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Pitts
Officer — President · Director · 10% Owner
Period of report
Sep 28, 2018
Accepted (ET)
Oct 22, 2018 · 12:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001630176
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 6,940 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred StockF1 | $0.00 | Sep 28, 2018 | P | 348,601 | A | Sep 28, 2018 | — | Common Stock | 576,435 | 576,435 | D |
| Series A Convertible Preferred StockF2,F1 | $0.00 | holding | — | — | — | Oct 17, 2017 | — | Common Stock | 20,402 | 20,402 | I |
Explanation of responses
- F1N/A
- F2Shares acquired in exchange of 15,000 shares of common stock of Eqova Life Sciences as part of the Company's acquisition of Eqova Life Sciences on October 17, 2017.